Teva’s Shared Solutions® is committed to helping your patients find affordable access to AJOVY
Patient Services PortalThe support team at CoverMyMeds® can help resolve or automatically initiate PA requests
CoverMyMeds®With AJOVY, patients may experience significantly more migraine-free days vs placebo, and lasting protection against migraine1*
Learn more about efficacy results for AJOVY*“Lasting protection” defined as reduction in monthly average migraine or headache days measured over a 12-week period following a monthly 225 mg SC dose or quarterly 675 (225 mg x 3) SC dose.1
SC: subcutaneous.
Teva’s Shared Solutions® is committed to helping your patients find affordable access to AJOVY
Patient Services PortalThe support team at CoverMyMeds® can help resolve or automatically initiate PA requests
CoverMyMeds®